Cullinan Therapeutics Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Cullinan Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $31.45. The average 1-year stock price forecast is 127.24% higher than the current stock price, while the lowest is $23 (+66.18%) and the highest is $38 (+174.57%).

Price Target: $31.45 (+127.24%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$23	$31.45	$30	$38
Change	+66.18%	+127.24%	+116.76%	+174.57%

Analyst Ratings

The average analyst rating for Cullinan Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	6	6	8	7	6	5
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	10	9	8	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Julian Harrison BTIG	BTIG	Strong Buy Reiterates $38	Strong Buy	Reiterates	$38	+174.57%	May 19, 2026
Robert Driscoll Wedbush	Wedbush	Buy Maintains $36 → $37	Buy	Maintains	$36 → $37	+167.34%	May 8, 2026
Julian Harrison BTIG	BTIG	Strong Buy Reiterates $38	Strong Buy	Reiterates	$38	+174.57%	May 4, 2026
Julian Harrison BTIG	BTIG	Strong Buy Reiterates $38	Strong Buy	Reiterates	$38	+174.57%	Apr 28, 2026
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $27 → $30	Strong Buy	Maintains	$27 → $30	+116.76%	Apr 28, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

6.53M

Revenue Next Year

37.69M

from 6.53M

477.56%

from 6.53M

EPS This Year

-3.20

from -3.72

EPS Next Year

-2.34

from -3.20

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	18.94M	-	-	-	-	6.53M	37.69M
Revenue Growth	-	-	-	-	-	-	477.56%
EPS	-1.52	2.38	-3.69	-3.11	-3.72	-3.20	-2.34
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	15	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	49.6M	136.5M
Avg	6.5M	37.7M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	1,992.0%
Avg	-	477.6%
Low	-	-

EPS Forecast

EPS	2026	2027
High	-2.32	-0.36
Avg	-3.20	-2.34
Low	-3.61	-3.21

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.